Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, TeslaBenzinga • 01/11/23
Strength Seen in Exact Sciences (EXAS): Can Its 24.7% Jump Turn into More Strength?Zacks Investment Research • 01/10/23
Exact Sciences Breaks Up From This Pattern, Signals Massive Reversal: Is A Bull Cycle In The Cards? - Exact Sciences (NASDAQ:EXAS)Benzinga • 01/09/23
NYSE Exec: There's 1 Stock In Cathie Wood's Fund That's Ready To Rise (It's Not Tesla)Benzinga • 01/05/23
Cathie Wood Has Bet Big On These 10 Stocks; Here's How They're PerformingInvestors Business Daily • 12/28/22
Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard TestPRNewsWire • 12/20/22
Exact Sciences (EXAS) Crossed Above the 20-Day Moving Average: What That Means for InvestorsZacks Investment Research • 12/19/22
Exact Sciences (EXAS) Crossed Above the 200-Day Moving Average: What That Means for InvestorsZacks Investment Research • 12/19/22
Guardant Health stock plunges, Exact Sciences rises on contrasting colorectal cancer detection testsProactive Investors • 12/16/22
Exact Sciences Rockets As Guardant's Blood Test Pales Vs. CologuardInvestors Business Daily • 12/15/22
Guardant Health stock plunges, Exact Sciences stock soars after colorectal-cancer test study resultsMarket Watch • 12/15/22
After-Hours Action: What's Going On With Guardant Health, Exact Sciences Shares? - Exact Sciences (NASDAQ:EXAS)Benzinga • 12/15/22